Disease-awareness ads lead to overdiagnosis, boost Rx sales

ModernHealthcare, 22 May 2017
Author: Alex Kacik
“Ads that try to bring awareness of diseases boost prescription drug sales and over diagnosis in the U.S., according to a new study. There is a fine line between direct-to-consumer drug ads, which the Food and Drug Administration regulates, and ads meant to create disease awareness that often skirt the purview of the FDA, per the article published in JAMA. Disease awareness advertisements, particularly for conditions that only have one approved drug treatment, can bolster drug sales and lead to “inappropriate” prescriptions as patients turn to their doctors and request the drugs they see advertised.”
Find article here.